SMN2 and proximal spinal muscular atrophy: As levels of complete SMN2 transcripts are generally inversely correlated with SMA severity, the development of SMA therapies began by screening for modifiers of SMN2 mRNA splicing to facilitate inclusion of exon 7, thereby increasing the production of full-length SMN2 transcripts.